Please assess the completion status of the following clinical trial:

Trial Title: Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All consecutive cirrhotic patients who have undergone TIPS at our Department for bleeding of esophagogastric varices refractory to medical or endoscopic treatment or for ascites/hydrothorax refractory to diuretic therapy will be considered eligible for the study.~Exclusion Criteria:~* an age \>75 years; past or present history of hepatic encephalopathy;~* a Z-score at trial making test-A (TMT-A) \>1.5;~* bilirubine levels \>5 mg/dl;~* creatinine levels \>3 mg/dl;~* serious cardiac or pulmonary dysfunction;~* a Child-Pugh's score \>11;~* a model end-stage liver disease (MELD) score \>18;~* portal thrombosis;~* a diagnosis of hepatic carcinoma;~* sepsis;~* spontaneous bacterial peritonitis;~* renal insufficiency.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): patients treated with 10 mm stent
- 2 (Type: ACTIVE_COMPARATOR): patients treated with 8 mm stent

Based on this trial design, predict the completion outcome and termination type (if applicable).